EGM
SGMO

Engineers Gate Manager’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Engineers Gate Manager’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.3K Buy
94,244
+37,690
+67% +$15K ﹤0.01% 2116
2025
Q4 		$23.8K Sell
56,554
-185,909
-77% -$98.5K ﹤0.01% 2022
2025
Q3 		$163K Buy
242,463
+155,038
+177% +$83.6K ﹤0.01% 1948
2025
Q2 		$47.3K Buy
87,425
+44,078
+102% +$26.2K ﹤0.01% 2051
2025
Q1 		$28.4K Sell
43,347
-11,592
-21% -$12.3K ﹤0.01% 2069
2024
Q4 		$56K Buy
54,939
+9,499
+21% +$17.4K ﹤0.01% 2070
2024
Q3 		$39.4K Sell
45,440
-11,115
-20% -$8.14K ﹤0.01% 1994
2024
Q2 		$20.3K Buy
56,555
+1,618
+3% +$874 ﹤0.01% 1854
2024
Q1 		$36.8K Sell
54,937
-1,618
-3% -$1.17K ﹤0.01% 1820
2023
Q4 		$30.7K Buy
56,555
+17,436
+45% +$8.04K ﹤0.01% 1882
2023
Q3 		$23.5K Sell
39,119
-2,992
-7% -$3.2K ﹤0.01% 1699
2023
Q2 		$54.7K Buy
+42,111
New +$57.5K ﹤0.01% 1616
2022
Q4 		– Sell
-16,290
Closed -$80K – 1997
2022
Q3 		$80K Buy
+16,290
New +$83.7K 0.01% 1467
2022
Q2 		– Sell
-50,600
Closed -$294K – 2223
2022
Q1 		$294K Buy
50,600
+22,500
+80% +$134K 0.01% 1410
2021
Q4 		$211K Sell
28,100
-3,808
-12% -$33.1K 0.01% 1622
2021
Q3 		$287K Sell
31,908
-20,516
-39% -$203K 0.02% 1220
2021
Q2 		$628K Buy
52,424
+29,144
+125% +$330K 0.04% 708
2021
Q1 		$292K Buy
+23,280
New +$314K 0.01% 1335
2020
Q4 		– Sell
-92,845
Closed -$877K – 1951
2020
Q3 		$877K Buy
92,845
+13,421
+17% +$145K 0.04% 691
2020
Q2 		$712K Buy
+79,424
New +$737K 0.04% 768

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Engineers Gate Manager's SGMO Position: Q1 2026 in Review

Engineers Gate Manager increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 67% in Q1 2026, buying an estimated $15K and bringing the position to 94,244 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2116.

Engineers Gate Manager first reported a position in SGMO in Q2 2020 and has held it in 20 quarters since. The position peaked at $877K in Q3 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Engineers Gate Manager held 94,244 shares of SANGAMO THERAPEUTICS INC worth $23.3K as of Q1 2026.
  • Engineers Gate Manager bought 37,690 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $15K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #2116 holding.
  • Engineers Gate Manager first reported a position in SANGAMO THERAPEUTICS INC in Q2 2020 and has held it in 20 quarters since.
  • Engineers Gate Manager's SANGAMO THERAPEUTICS INC position peaked at $877K in Q3 2020.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.